Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04432298
What this trial is testing

Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease

Who this might be right for
COVID-19
Kyntra Bio 22
Testing effectiveness (Phase 2)Study completedNCT06244316
What this trial is testing

A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.

Who this might be right for
Dry Eye Disease
Dompé Farmaceutici S.p.A 317
Testing effectiveness (Phase 2)Study completedNCT00876187
What this trial is testing

Tanezumab in Adults With Chronic Low Back Pain

Who this might be right for
Low Back Pain
Pfizer 1,359
Not applicableStudy completedNCT06119347
What this trial is testing

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Who this might be right for
AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
First Affiliated Hospital of Wenzhou Medical University 1,581
Large-scale testing (Phase 3)Study completedNCT00970697
What this trial is testing

Becaplermin Gel for MARTORELL's Hypertensive Leg Ulcers

Who this might be right for
MARTORELL'S ULCERHypertensive Leg UlcerNecrotic Angiodermatitis
Assistance Publique - Hôpitaux de Paris 64
Testing effectiveness (Phase 2)Ended earlyNCT02095782
What this trial is testing

Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation

Who this might be right for
Non-small-cell Lung Cancer
Guangdong Association of Clinical Trials 10
Not applicableStudy completedNCT01953523
What this trial is testing

Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions

Who this might be right for
Neurodegenerative DiseasesOsteoarthritisErectile Dysfunction+3 more
Elliot Lander 3,000
Early research (Phase 1)Ended earlyNCT03284723
What this trial is testing

PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors

Who this might be right for
Breast Neoplasms
Pfizer 95
Testing effectiveness (Phase 2)Study completedNCT02970682
What this trial is testing

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Evgen Pharma 60
Early research (Phase 1)UnknownNCT02321293
What this trial is testing

Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC

Who this might be right for
Lung Cancer
Lady Davis Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT01918306
What this trial is testing

GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor Negative Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastTriple Negative Breast Cancer+3 more
Vanderbilt-Ingram Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02289833
What this trial is testing

Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 49
Early research (Phase 1)Study completedNCT00444015
What this trial is testing

Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 34
Not applicableStudy completedNCT06604390
What this trial is testing

THE EFFECTS OF GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION ON COGNITIVE FUNCTION, EXPRESSION OF APP, MAPT, BDNF, IL-10, TGF-Β GENES, AND PLASMA MDA LEVELS IN THE ELDERLY.

Who this might be right for
Elderly Individuals Aged 60 Years or OlderMild Cognitive Impairment (MCI)
Rahmi Novita Yusuf 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT05526755
What this trial is testing

5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)

Who this might be right for
Stage II-IIIB Non-small Cell Lung Carcinoma
AstraZeneca 188
Not applicableLooking for participantsNCT06975683
What this trial is testing

Open, Non-comparative Pilot Study to Evaluate the Safety and Efficacy of Intraovarian Plasma Rich in Growth Factors (PRGF) in Patients With Low Ovarian Reserve

Who this might be right for
Low Ovarian Reserve
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 50
Not applicableLooking for participantsNCT07015203
What this trial is testing

The Combined First Trimester Screening

Who this might be right for
Preeclampsia (PE)Fetal Growth RestrictionCongenital Abnormalities+4 more
Institute of Health Information and Statistics of the Czech Republic 2,000
Not applicableUnknownNCT04330027
What this trial is testing

Effectiveness of Lyophilized Growth Factors for Subacromial Impingement

Who this might be right for
Shoulder Impingement Syndrome
Alexandria University 60
Testing effectiveness (Phase 2)Study completedNCT00682383
What this trial is testing

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Unresectable Locally Advanced NSCLC
Mt. Sinai Medical Center, Miami 26
Testing effectiveness (Phase 2)Ended earlyNCT02192697
What this trial is testing

An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Non-small Cell Lung Cancer
Astellas Pharma Inc 124
Next Page